The store will not work correctly when cookies are disabled.
{3-[1-(3-Methoxy-phenyl)-2,2-dioxo-1,4-dihydro-2H-2lambda*6*-benzo[1,2,6]thiadiazin-3-yl]-propyl}-methyl-amine
ID: ALA1085904
PubChem CID: 25029546
Max Phase: Preclinical
Molecular Formula: C18H23N3O3S
Molecular Weight: 361.47
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CNCCCN1Cc2ccccc2N(c2cccc(OC)c2)S1(=O)=O
Standard InChI: InChI=1S/C18H23N3O3S/c1-19-11-6-12-20-14-15-7-3-4-10-18(15)21(25(20,22)23)16-8-5-9-17(13-16)24-2/h3-5,7-10,13,19H,6,11-12,14H2,1-2H3
Standard InChI Key: ZFGMAUXPSXKTKJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
23.6227 -0.1583 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.9102 -0.5749 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
23.6273 -0.9836 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.0549 0.2375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0537 -0.5897 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7685 -1.0026 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4849 -0.5893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4820 0.2412 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7667 0.6502 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1949 0.6563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9108 0.2466 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.6237 0.6616 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3396 0.2519 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0524 0.6670 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7683 0.2573 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.4813 0.6724 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1999 -1.0006 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.2066 -1.8229 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4943 -2.2412 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5013 -3.0653 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2199 -3.4722 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9329 -3.0489 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9224 -2.2262 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7904 -3.4838 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.0725 -3.0773 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12 13 1 0
2 1 2 0
13 14 1 0
7 8 1 0
14 15 1 0
4 5 2 0
15 16 1 0
11 2 1 0
2 17 1 0
8 9 2 0
7 17 1 0
9 4 1 0
3 2 2 0
18 19 2 0
8 10 1 0
19 20 1 0
5 6 1 0
20 21 2 0
10 11 1 0
21 22 1 0
22 23 2 0
23 18 1 0
17 18 1 0
11 12 1 0
20 24 1 0
6 7 2 0
24 25 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 361.47 | Molecular Weight (Monoisotopic): 361.1460 | AlogP: 2.50 | #Rotatable Bonds: 6 |
Polar Surface Area: 61.88 | Molecular Species: BASE | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 10.27 | CX LogP: 1.51 | CX LogD: -1.21 |
Aromatic Rings: 2 | Heavy Atoms: 25 | QED Weighted: 0.80 | Np Likeness Score: -0.90 |
References
1. Fensome A, Goldberg J, McComas CC, Trybulski EJ, Woodworth RP, Deecher DC, Whiteside GT, Zhang P.. (2010) Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores., 20 (5): [PMID:20153188] [10.1016/j.bmcl.2010.01.056] |